Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study
JLJosefina Lorena RazziniIGIago Giné-VázquezJJJing JinMSMaría-Isolina Santiago-PérezOPOlaia Pérez-Martínez
Universidade de Santiago de Compostela · Instituto de Investigación Sanitaria de Santiago · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
6
total citations
- FWCI
- 93.88
- Percentile
- 100%
- References
- 30
Too recent for citation history.
Authors
24- JLJosefina Lorena RazziniCorresponding
Universidade de Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago
- IGIago Giné-Vázquez
Instituto de Investigación Sanitaria de Santiago
- JJJing Jin
Sanofi (France)
- MSMaría-Isolina Santiago-Pérez
Xunta de Galicia
- OPOlaia Pérez-Martínez
Xunta de Galicia
Topics & keywords
Topics
Keywords
- Observational study
- Primary care
- Respiratory system
- Palivizumab
- Virus
- Prospective cohort study
- Incidence (geometry)
- Mononegavirales
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.
Funding
- AAstraZeneca
- MDMinisterio de Sanidad, Consumo y Bienestar SocialAward: GENVIP-IDIS-2021\u20132024
- ACAustralasian Centre for Italian Studies
- IDInstituto de Salud Carlos IIIAwards: OMI-COVI-VAC PI22/00406, PI19/01090, DTS19/00049, PI24/00757, PI19/01039, MANTRA-ID PI25/00725, PI16/01569, TRINEO PI22/00162, PNEUMOVAI PI25/01405
- EREuropean Regional Development FundAwards: GAIN IN607B 2020/08, GEN-COVID IN845D 2020/23, IIN607A2021/05, IN607A 2023/02